Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

The 2024 Yellow Book updates shift auditors toward a proactive System of Quality Management. Weaver provides insights and tools to help teams adapt.
From AI and capital markets to cyber and PCAOB focus areas, find summaries and questions for board members on these key topics.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
Weaver’s team quantified damages and provided testimony, helping a client secure a verdict of nearly $3.5 million in a complex legal dispute.
Hidden assets, global reach. Weaver’s forensics and litigation services team led a cross-border investigation supporting a €45 million outcome.
Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
Divorce misconceptions can complicate cases. Weaver shows how clear financial records help clarify assets, support fair outcomes and reduce conflict.
Weaver’s forensics team conducted pre-transaction due diligence, unveiling regulatory, legal and operational risks for a high-profile global developer.
Learn how AI supports smarter, faster SOX compliance. Weaver’s Second Line Ready series guides you through a disciplined approach and safe execution.
Premarital and LLC agreements can override statutory defaults in divorce valuations. The In re S.R.W. case shows how they reshape economic interests.
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
Weaver’s forensic due diligence uncovered hidden risks that helped a private equity firm restructure its deal and reduce exposure.
1 2 3 4 37